nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—ABCB1—colon cancer	0.352	1	CbGaD
Clarithromycin—SLC22A7—Fluorouracil—colon cancer	0.116	0.22	CbGbCtD
Clarithromycin—SLC22A7—Methotrexate—colon cancer	0.0639	0.121	CbGbCtD
Clarithromycin—CYP3A7—Irinotecan—colon cancer	0.0469	0.0889	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0469	0.0889	CbGbCtD
Clarithromycin—CYP3A7—Vincristine—colon cancer	0.041	0.0777	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.041	0.0777	CbGbCtD
Clarithromycin—CYP3A5—Irinotecan—colon cancer	0.0352	0.0667	CbGbCtD
Clarithromycin—CYP3A5—Vincristine—colon cancer	0.0307	0.0583	CbGbCtD
Clarithromycin—CYP1A2—Fluorouracil—colon cancer	0.0251	0.0476	CbGbCtD
Clarithromycin—ABCB1—Irinotecan—colon cancer	0.0229	0.0434	CbGbCtD
Clarithromycin—ABCB1—Vincristine—colon cancer	0.02	0.0379	CbGbCtD
Clarithromycin—CYP3A4—Irinotecan—colon cancer	0.0137	0.026	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—colon cancer	0.0121	0.023	CbGbCtD
Clarithromycin—CYP3A4—Vincristine—colon cancer	0.012	0.0227	CbGbCtD
Clarithromycin—Roxithromycin—ABCB1—colon cancer	0.00076	0.291	CrCbGaD
Clarithromycin—Azithromycin—ABCB1—colon cancer	0.00076	0.291	CrCbGaD
Clarithromycin—Troleandomycin—ABCB1—colon cancer	0.000585	0.224	CrCbGaD
Clarithromycin—Erythromycin—ABCB1—colon cancer	0.000507	0.194	CrCbGaD
Clarithromycin—Renal failure—Capecitabine—colon cancer	0.000255	0.00215	CcSEcCtD
Clarithromycin—Discomfort—Irinotecan—colon cancer	0.000254	0.00215	CcSEcCtD
Clarithromycin—Anaphylactic shock—Vincristine—colon cancer	0.000253	0.00214	CcSEcCtD
Clarithromycin—Stomatitis—Capecitabine—colon cancer	0.000252	0.00213	CcSEcCtD
Clarithromycin—Jaundice—Capecitabine—colon cancer	0.000252	0.00213	CcSEcCtD
Clarithromycin—Infection—Vincristine—colon cancer	0.000252	0.00212	CcSEcCtD
Clarithromycin—Conjunctivitis—Capecitabine—colon cancer	0.000252	0.00212	CcSEcCtD
Clarithromycin—Convulsion—Fluorouracil—colon cancer	0.000251	0.00212	CcSEcCtD
Clarithromycin—Confusional state—Irinotecan—colon cancer	0.000249	0.0021	CcSEcCtD
Clarithromycin—Nervous system disorder—Vincristine—colon cancer	0.000248	0.0021	CcSEcCtD
Clarithromycin—Thrombocytopenia—Vincristine—colon cancer	0.000248	0.00209	CcSEcCtD
Clarithromycin—Haematuria—Capecitabine—colon cancer	0.000247	0.00208	CcSEcCtD
Clarithromycin—Anaphylactic shock—Irinotecan—colon cancer	0.000247	0.00208	CcSEcCtD
Clarithromycin—Myalgia—Fluorouracil—colon cancer	0.000247	0.00208	CcSEcCtD
Clarithromycin—Chest pain—Fluorouracil—colon cancer	0.000247	0.00208	CcSEcCtD
Clarithromycin—Infection—Irinotecan—colon cancer	0.000245	0.00207	CcSEcCtD
Clarithromycin—Hyperhidrosis—Vincristine—colon cancer	0.000245	0.00207	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Capecitabine—colon cancer	0.000245	0.00207	CcSEcCtD
Clarithromycin—Epistaxis—Capecitabine—colon cancer	0.000244	0.00206	CcSEcCtD
Clarithromycin—Discomfort—Fluorouracil—colon cancer	0.000244	0.00206	CcSEcCtD
Clarithromycin—Nervous system disorder—Irinotecan—colon cancer	0.000242	0.00204	CcSEcCtD
Clarithromycin—Agranulocytosis—Capecitabine—colon cancer	0.000242	0.00204	CcSEcCtD
Clarithromycin—Thrombocytopenia—Irinotecan—colon cancer	0.000242	0.00204	CcSEcCtD
Clarithromycin—Anorexia—Vincristine—colon cancer	0.000242	0.00204	CcSEcCtD
Clarithromycin—Hyperhidrosis—Irinotecan—colon cancer	0.000239	0.00201	CcSEcCtD
Clarithromycin—Confusional state—Fluorouracil—colon cancer	0.000238	0.00201	CcSEcCtD
Clarithromycin—Anaphylactic shock—Fluorouracil—colon cancer	0.000236	0.00199	CcSEcCtD
Clarithromycin—Anorexia—Irinotecan—colon cancer	0.000235	0.00199	CcSEcCtD
Clarithromycin—Infection—Fluorouracil—colon cancer	0.000235	0.00198	CcSEcCtD
Clarithromycin—Haemoglobin—Capecitabine—colon cancer	0.000234	0.00197	CcSEcCtD
Clarithromycin—Rhinitis—Capecitabine—colon cancer	0.000233	0.00197	CcSEcCtD
Clarithromycin—Haemorrhage—Capecitabine—colon cancer	0.000232	0.00196	CcSEcCtD
Clarithromycin—Hepatitis—Capecitabine—colon cancer	0.000232	0.00196	CcSEcCtD
Clarithromycin—Nervous system disorder—Fluorouracil—colon cancer	0.000232	0.00196	CcSEcCtD
Clarithromycin—Thrombocytopenia—Fluorouracil—colon cancer	0.000231	0.00195	CcSEcCtD
Clarithromycin—Liver function test abnormal—Methotrexate—colon cancer	0.000231	0.00195	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000231	0.00195	CcSEcCtD
Clarithromycin—Pharyngitis—Capecitabine—colon cancer	0.000231	0.00195	CcSEcCtD
Clarithromycin—Urinary tract disorder—Capecitabine—colon cancer	0.00023	0.00194	CcSEcCtD
Clarithromycin—Insomnia—Vincristine—colon cancer	0.000229	0.00193	CcSEcCtD
Clarithromycin—Connective tissue disorder—Capecitabine—colon cancer	0.000228	0.00193	CcSEcCtD
Clarithromycin—Urethral disorder—Capecitabine—colon cancer	0.000228	0.00192	CcSEcCtD
Clarithromycin—Paraesthesia—Vincristine—colon cancer	0.000227	0.00192	CcSEcCtD
Clarithromycin—Breast disorder—Methotrexate—colon cancer	0.000226	0.00191	CcSEcCtD
Clarithromycin—Anorexia—Fluorouracil—colon cancer	0.000225	0.0019	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000225	0.0019	CcSEcCtD
Clarithromycin—Visual impairment—Capecitabine—colon cancer	0.000224	0.00189	CcSEcCtD
Clarithromycin—Insomnia—Irinotecan—colon cancer	0.000223	0.00188	CcSEcCtD
Clarithromycin—Paraesthesia—Irinotecan—colon cancer	0.000222	0.00187	CcSEcCtD
Clarithromycin—Decreased appetite—Vincristine—colon cancer	0.00022	0.00186	CcSEcCtD
Clarithromycin—Dyspnoea—Irinotecan—colon cancer	0.00022	0.00186	CcSEcCtD
Clarithromycin—Erythema multiforme—Capecitabine—colon cancer	0.00022	0.00186	CcSEcCtD
Clarithromycin—Somnolence—Irinotecan—colon cancer	0.000219	0.00185	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Vincristine—colon cancer	0.000219	0.00185	CcSEcCtD
Clarithromycin—Fatigue—Vincristine—colon cancer	0.000218	0.00184	CcSEcCtD
Clarithromycin—Eye disorder—Capecitabine—colon cancer	0.000217	0.00183	CcSEcCtD
Clarithromycin—Dyspepsia—Irinotecan—colon cancer	0.000217	0.00183	CcSEcCtD
Clarithromycin—Tinnitus—Capecitabine—colon cancer	0.000217	0.00183	CcSEcCtD
Clarithromycin—Constipation—Vincristine—colon cancer	0.000217	0.00183	CcSEcCtD
Clarithromycin—Pain—Vincristine—colon cancer	0.000217	0.00183	CcSEcCtD
Clarithromycin—Asthma—Methotrexate—colon cancer	0.000216	0.00182	CcSEcCtD
Clarithromycin—Flushing—Capecitabine—colon cancer	0.000216	0.00182	CcSEcCtD
Clarithromycin—Cardiac disorder—Capecitabine—colon cancer	0.000216	0.00182	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000215	0.00182	CcSEcCtD
Clarithromycin—Decreased appetite—Irinotecan—colon cancer	0.000214	0.00181	CcSEcCtD
Clarithromycin—Eosinophilia—Methotrexate—colon cancer	0.000214	0.00181	CcSEcCtD
Clarithromycin—Insomnia—Fluorouracil—colon cancer	0.000214	0.0018	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000213	0.0018	CcSEcCtD
Clarithromycin—Fatigue—Irinotecan—colon cancer	0.000213	0.0018	CcSEcCtD
Clarithromycin—Paraesthesia—Fluorouracil—colon cancer	0.000212	0.00179	CcSEcCtD
Clarithromycin—Pancreatitis—Methotrexate—colon cancer	0.000212	0.00179	CcSEcCtD
Clarithromycin—Constipation—Irinotecan—colon cancer	0.000211	0.00178	CcSEcCtD
Clarithromycin—Pain—Irinotecan—colon cancer	0.000211	0.00178	CcSEcCtD
Clarithromycin—Angiopathy—Capecitabine—colon cancer	0.000211	0.00178	CcSEcCtD
Clarithromycin—Dyspnoea—Fluorouracil—colon cancer	0.000211	0.00178	CcSEcCtD
Clarithromycin—Somnolence—Fluorouracil—colon cancer	0.00021	0.00177	CcSEcCtD
Clarithromycin—Immune system disorder—Capecitabine—colon cancer	0.00021	0.00177	CcSEcCtD
Clarithromycin—Mediastinal disorder—Capecitabine—colon cancer	0.000209	0.00177	CcSEcCtD
Clarithromycin—Chills—Capecitabine—colon cancer	0.000209	0.00176	CcSEcCtD
Clarithromycin—Dyspepsia—Fluorouracil—colon cancer	0.000208	0.00176	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Vincristine—colon cancer	0.000207	0.00175	CcSEcCtD
Clarithromycin—Decreased appetite—Fluorouracil—colon cancer	0.000205	0.00173	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000204	0.00172	CcSEcCtD
Clarithromycin—Mental disorder—Capecitabine—colon cancer	0.000204	0.00172	CcSEcCtD
Clarithromycin—Feeling abnormal—Irinotecan—colon cancer	0.000203	0.00172	CcSEcCtD
Clarithromycin—Malnutrition—Capecitabine—colon cancer	0.000202	0.00171	CcSEcCtD
Clarithromycin—Dysuria—Methotrexate—colon cancer	0.000202	0.00171	CcSEcCtD
Clarithromycin—Neutropenia—Methotrexate—colon cancer	0.000202	0.00171	CcSEcCtD
Clarithromycin—Pain—Fluorouracil—colon cancer	0.000202	0.00171	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Irinotecan—colon cancer	0.000202	0.0017	CcSEcCtD
Clarithromycin—Abdominal pain—Vincristine—colon cancer	0.0002	0.00169	CcSEcCtD
Clarithromycin—Body temperature increased—Vincristine—colon cancer	0.0002	0.00169	CcSEcCtD
Clarithromycin—Flatulence—Capecitabine—colon cancer	0.000199	0.00168	CcSEcCtD
Clarithromycin—Dysgeusia—Capecitabine—colon cancer	0.000198	0.00167	CcSEcCtD
Clarithromycin—Back pain—Capecitabine—colon cancer	0.000196	0.00165	CcSEcCtD
Clarithromycin—Abdominal pain—Irinotecan—colon cancer	0.000195	0.00165	CcSEcCtD
Clarithromycin—Body temperature increased—Irinotecan—colon cancer	0.000195	0.00165	CcSEcCtD
Clarithromycin—Feeling abnormal—Fluorouracil—colon cancer	0.000195	0.00164	CcSEcCtD
Clarithromycin—Muscle spasms—Capecitabine—colon cancer	0.000195	0.00164	CcSEcCtD
Clarithromycin—Pneumonia—Methotrexate—colon cancer	0.000194	0.00164	CcSEcCtD
Clarithromycin—Infestation—Methotrexate—colon cancer	0.000193	0.00163	CcSEcCtD
Clarithromycin—Infestation NOS—Methotrexate—colon cancer	0.000193	0.00163	CcSEcCtD
Clarithromycin—Depression—Methotrexate—colon cancer	0.000192	0.00162	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000191	0.00161	CcSEcCtD
Clarithromycin—Tremor—Capecitabine—colon cancer	0.00019	0.0016	CcSEcCtD
Clarithromycin—Renal failure—Methotrexate—colon cancer	0.000189	0.0016	CcSEcCtD
Clarithromycin—Stomatitis—Methotrexate—colon cancer	0.000188	0.00159	CcSEcCtD
Clarithromycin—Ill-defined disorder—Capecitabine—colon cancer	0.000188	0.00158	CcSEcCtD
Clarithromycin—Urticaria—Fluorouracil—colon cancer	0.000188	0.00158	CcSEcCtD
Clarithromycin—Conjunctivitis—Methotrexate—colon cancer	0.000187	0.00158	CcSEcCtD
Clarithromycin—Anaemia—Capecitabine—colon cancer	0.000187	0.00158	CcSEcCtD
Clarithromycin—Body temperature increased—Fluorouracil—colon cancer	0.000187	0.00158	CcSEcCtD
Clarithromycin—Hypersensitivity—Vincristine—colon cancer	0.000187	0.00158	CcSEcCtD
Clarithromycin—Haematuria—Methotrexate—colon cancer	0.000184	0.00155	CcSEcCtD
Clarithromycin—Malaise—Capecitabine—colon cancer	0.000182	0.00154	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Methotrexate—colon cancer	0.000182	0.00154	CcSEcCtD
Clarithromycin—Epistaxis—Methotrexate—colon cancer	0.000182	0.00153	CcSEcCtD
Clarithromycin—Vertigo—Capecitabine—colon cancer	0.000182	0.00153	CcSEcCtD
Clarithromycin—Hypersensitivity—Irinotecan—colon cancer	0.000182	0.00153	CcSEcCtD
Clarithromycin—Asthenia—Vincristine—colon cancer	0.000182	0.00153	CcSEcCtD
Clarithromycin—Leukopenia—Capecitabine—colon cancer	0.000181	0.00153	CcSEcCtD
Clarithromycin—Agranulocytosis—Methotrexate—colon cancer	0.00018	0.00152	CcSEcCtD
Clarithromycin—Palpitations—Capecitabine—colon cancer	0.000179	0.00151	CcSEcCtD
Clarithromycin—Loss of consciousness—Capecitabine—colon cancer	0.000178	0.0015	CcSEcCtD
Clarithromycin—Asthenia—Irinotecan—colon cancer	0.000177	0.00149	CcSEcCtD
Clarithromycin—Cough—Capecitabine—colon cancer	0.000177	0.00149	CcSEcCtD
Clarithromycin—Hypersensitivity—Fluorouracil—colon cancer	0.000174	0.00147	CcSEcCtD
Clarithromycin—Haemoglobin—Methotrexate—colon cancer	0.000174	0.00147	CcSEcCtD
Clarithromycin—Diarrhoea—Vincristine—colon cancer	0.000173	0.00146	CcSEcCtD
Clarithromycin—Hepatitis—Methotrexate—colon cancer	0.000173	0.00146	CcSEcCtD
Clarithromycin—Haemorrhage—Methotrexate—colon cancer	0.000173	0.00146	CcSEcCtD
Clarithromycin—Myalgia—Capecitabine—colon cancer	0.000172	0.00145	CcSEcCtD
Clarithromycin—Chest pain—Capecitabine—colon cancer	0.000172	0.00145	CcSEcCtD
Clarithromycin—Pharyngitis—Methotrexate—colon cancer	0.000172	0.00145	CcSEcCtD
Clarithromycin—Anxiety—Capecitabine—colon cancer	0.000172	0.00145	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000171	0.00144	CcSEcCtD
Clarithromycin—Urinary tract disorder—Methotrexate—colon cancer	0.000171	0.00144	CcSEcCtD
Clarithromycin—Discomfort—Capecitabine—colon cancer	0.00017	0.00144	CcSEcCtD
Clarithromycin—Urethral disorder—Methotrexate—colon cancer	0.00017	0.00143	CcSEcCtD
Clarithromycin—Diarrhoea—Irinotecan—colon cancer	0.000169	0.00143	CcSEcCtD
Clarithromycin—Dry mouth—Capecitabine—colon cancer	0.000168	0.00142	CcSEcCtD
Clarithromycin—Dizziness—Vincristine—colon cancer	0.000168	0.00141	CcSEcCtD
Clarithromycin—Pruritus—Fluorouracil—colon cancer	0.000167	0.00141	CcSEcCtD
Clarithromycin—Visual impairment—Methotrexate—colon cancer	0.000167	0.00141	CcSEcCtD
Clarithromycin—Confusional state—Capecitabine—colon cancer	0.000167	0.00141	CcSEcCtD
Clarithromycin—Infection—Capecitabine—colon cancer	0.000164	0.00138	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—colon cancer	0.000164	0.00138	CcSEcCtD
Clarithromycin—Dizziness—Irinotecan—colon cancer	0.000163	0.00138	CcSEcCtD
Clarithromycin—Nervous system disorder—Capecitabine—colon cancer	0.000162	0.00137	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—colon cancer	0.000162	0.00136	CcSEcCtD
Clarithromycin—Diarrhoea—Fluorouracil—colon cancer	0.000162	0.00136	CcSEcCtD
Clarithromycin—Thrombocytopenia—Capecitabine—colon cancer	0.000162	0.00136	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—colon cancer	0.000161	0.00136	CcSEcCtD
Clarithromycin—Vomiting—Vincristine—colon cancer	0.000161	0.00136	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—colon cancer	0.000161	0.00136	CcSEcCtD
Clarithromycin—Skin disorder—Capecitabine—colon cancer	0.00016	0.00135	CcSEcCtD
Clarithromycin—Rash—Vincristine—colon cancer	0.00016	0.00135	CcSEcCtD
Clarithromycin—Hyperhidrosis—Capecitabine—colon cancer	0.00016	0.00135	CcSEcCtD
Clarithromycin—Dermatitis—Vincristine—colon cancer	0.00016	0.00135	CcSEcCtD
Clarithromycin—Headache—Vincristine—colon cancer	0.000159	0.00134	CcSEcCtD
Clarithromycin—Anorexia—Capecitabine—colon cancer	0.000157	0.00133	CcSEcCtD
Clarithromycin—Angiopathy—Methotrexate—colon cancer	0.000157	0.00133	CcSEcCtD
Clarithromycin—Vomiting—Irinotecan—colon cancer	0.000157	0.00132	CcSEcCtD
Clarithromycin—Immune system disorder—Methotrexate—colon cancer	0.000156	0.00132	CcSEcCtD
Clarithromycin—Dizziness—Fluorouracil—colon cancer	0.000156	0.00132	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—colon cancer	0.000156	0.00132	CcSEcCtD
Clarithromycin—Rash—Irinotecan—colon cancer	0.000156	0.00131	CcSEcCtD
Clarithromycin—Dermatitis—Irinotecan—colon cancer	0.000155	0.00131	CcSEcCtD
Clarithromycin—Chills—Methotrexate—colon cancer	0.000155	0.00131	CcSEcCtD
Clarithromycin—Headache—Irinotecan—colon cancer	0.000155	0.0013	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—colon cancer	0.000152	0.00128	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—colon cancer	0.000151	0.00127	CcSEcCtD
Clarithromycin—Nausea—Vincristine—colon cancer	0.00015	0.00127	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00015	0.00127	CcSEcCtD
Clarithromycin—Vomiting—Fluorouracil—colon cancer	0.00015	0.00127	CcSEcCtD
Clarithromycin—Insomnia—Capecitabine—colon cancer	0.000149	0.00126	CcSEcCtD
Clarithromycin—Rash—Fluorouracil—colon cancer	0.000149	0.00126	CcSEcCtD
Clarithromycin—Dermatitis—Fluorouracil—colon cancer	0.000149	0.00126	CcSEcCtD
Clarithromycin—Paraesthesia—Capecitabine—colon cancer	0.000148	0.00125	CcSEcCtD
Clarithromycin—Headache—Fluorouracil—colon cancer	0.000148	0.00125	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—colon cancer	0.000148	0.00125	CcSEcCtD
Clarithromycin—Dyspnoea—Capecitabine—colon cancer	0.000147	0.00124	CcSEcCtD
Clarithromycin—Nausea—Irinotecan—colon cancer	0.000147	0.00124	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—colon cancer	0.000146	0.00123	CcSEcCtD
Clarithromycin—Dyspepsia—Capecitabine—colon cancer	0.000145	0.00123	CcSEcCtD
Clarithromycin—Decreased appetite—Capecitabine—colon cancer	0.000144	0.00121	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000143	0.0012	CcSEcCtD
Clarithromycin—Fatigue—Capecitabine—colon cancer	0.000142	0.0012	CcSEcCtD
Clarithromycin—Pain—Capecitabine—colon cancer	0.000141	0.00119	CcSEcCtD
Clarithromycin—Constipation—Capecitabine—colon cancer	0.000141	0.00119	CcSEcCtD
Clarithromycin—Nausea—Fluorouracil—colon cancer	0.00014	0.00118	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—colon cancer	0.00014	0.00118	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—colon cancer	0.000139	0.00118	CcSEcCtD
Clarithromycin—Feeling abnormal—Capecitabine—colon cancer	0.000136	0.00115	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—colon cancer	0.000136	0.00115	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—colon cancer	0.000135	0.00114	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Capecitabine—colon cancer	0.000135	0.00114	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—colon cancer	0.000135	0.00114	CcSEcCtD
Clarithromycin—Cough—Methotrexate—colon cancer	0.000131	0.00111	CcSEcCtD
Clarithromycin—Urticaria—Capecitabine—colon cancer	0.000131	0.00111	CcSEcCtD
Clarithromycin—Abdominal pain—Capecitabine—colon cancer	0.000131	0.0011	CcSEcCtD
Clarithromycin—Body temperature increased—Capecitabine—colon cancer	0.000131	0.0011	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—colon cancer	0.000131	0.0011	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—colon cancer	0.000128	0.00108	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—colon cancer	0.000128	0.00108	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000127	0.00108	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—colon cancer	0.000127	0.00107	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—colon cancer	0.000124	0.00105	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—colon cancer	0.000123	0.00104	CcSEcCtD
Clarithromycin—Infection—Methotrexate—colon cancer	0.000122	0.00103	CcSEcCtD
Clarithromycin—Hypersensitivity—Capecitabine—colon cancer	0.000122	0.00103	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—colon cancer	0.000121	0.00102	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—colon cancer	0.00012	0.00102	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—colon cancer	0.000119	0.00101	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—colon cancer	0.000119	0.001	CcSEcCtD
Clarithromycin—Asthenia—Capecitabine—colon cancer	0.000118	0.001	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—colon cancer	0.000117	0.000989	CcSEcCtD
Clarithromycin—Pruritus—Capecitabine—colon cancer	0.000117	0.000986	CcSEcCtD
Clarithromycin—Diarrhoea—Capecitabine—colon cancer	0.000113	0.000954	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000112	0.000945	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—colon cancer	0.000111	0.000939	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—colon cancer	0.00011	0.000932	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—colon cancer	0.00011	0.000925	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—colon cancer	0.000109	0.000923	CcSEcCtD
Clarithromycin—Dizziness—Capecitabine—colon cancer	0.000109	0.000922	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—colon cancer	0.000108	0.000913	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—colon cancer	0.000107	0.000902	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000106	0.000896	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—colon cancer	0.000106	0.000895	CcSEcCtD
Clarithromycin—Pain—Methotrexate—colon cancer	0.000105	0.000887	CcSEcCtD
Clarithromycin—Vomiting—Capecitabine—colon cancer	0.000105	0.000886	CcSEcCtD
Clarithromycin—Rash—Capecitabine—colon cancer	0.000104	0.000879	CcSEcCtD
Clarithromycin—Dermatitis—Capecitabine—colon cancer	0.000104	0.000878	CcSEcCtD
Clarithromycin—Headache—Capecitabine—colon cancer	0.000103	0.000873	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—colon cancer	0.000101	0.000855	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—colon cancer	0.000101	0.000849	CcSEcCtD
Clarithromycin—Nausea—Capecitabine—colon cancer	9.81e-05	0.000828	CcSEcCtD
Clarithromycin—Urticaria—Methotrexate—colon cancer	9.77e-05	0.000824	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—colon cancer	9.72e-05	0.00082	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—colon cancer	9.72e-05	0.00082	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—colon cancer	9.06e-05	0.000765	CcSEcCtD
Clarithromycin—Asthenia—Methotrexate—colon cancer	8.82e-05	0.000745	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—colon cancer	8.7e-05	0.000734	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—colon cancer	8.41e-05	0.00071	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—colon cancer	8.13e-05	0.000686	CcSEcCtD
Clarithromycin—Vomiting—Methotrexate—colon cancer	7.82e-05	0.00066	CcSEcCtD
Clarithromycin—Rash—Methotrexate—colon cancer	7.75e-05	0.000654	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—colon cancer	7.74e-05	0.000654	CcSEcCtD
Clarithromycin—Headache—Methotrexate—colon cancer	7.7e-05	0.00065	CcSEcCtD
Clarithromycin—Nausea—Methotrexate—colon cancer	7.3e-05	0.000616	CcSEcCtD
